HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Heat shock protein gp96 adjuvant induces T cell responses and cross-protection to a split influenza vaccine.

Abstract
The commonly used inactivated or split influenza vaccines induce only induce minimal T cell responses and are less effective in preventing heterologous virus infection. Thus, developing cross-protective influenza vaccines against the spread of a new influenza virus is an important strategy against pandemic emergence. Here we demonstrated that immunization with heat shock protein gp96 as adjuvant led to a dramatic increased antigen-specific T cell response to a pandemic H1N1 split vaccine. Notably, gp96 elicited a cross-protective CD8(+) T cell response to the internal conserved viral protein NP. Although the split pH1N1vaccine alone has low cross-protective efficiency, adding gp96 as an adjuvant effectively improved the cross-protection against challenge with a heterologous virus in mice. Our study reveals the novel property of gp96 in boosting the T cell response against conserved epitopes of influenza virus and its potential use as an adjuvant for human pre-pandemic inactivated influenza vaccines against different viral subtypes.
AuthorsYing Ju, Hongxia Fan, Jun Liu, Jun Hu, Xinghui Li, Changfei Li, Lizhao Chen, Qiang Gao, George F Gao, Songdong Meng
JournalVaccine (Vaccine) Vol. 32 Issue 23 Pg. 2703-11 (May 13 2014) ISSN: 1873-2518 [Electronic] Netherlands
PMID24699472 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2014 Elsevier Ltd. All rights reserved.
Chemical References
  • Adjuvants, Immunologic
  • Antibodies, Viral
  • Heat-Shock Proteins
  • Influenza Vaccines
Topics
  • Adjuvants, Immunologic (pharmacology)
  • Animals
  • Antibodies, Viral (blood)
  • CD8-Positive T-Lymphocytes (immunology)
  • Cross Protection
  • Female
  • Heat-Shock Proteins (pharmacology)
  • Hemagglutination Inhibition Tests
  • Immunity, Cellular
  • Immunity, Humoral
  • Influenza A Virus, H1N1 Subtype
  • Influenza Vaccines (immunology)
  • Mice, Inbred BALB C
  • Neutralization Tests
  • Orthomyxoviridae Infections (prevention & control)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: